Cancer Research UK. Brain cancer (C71): 2010-2011. One-, five- and ten-year net survival (%), adults aged 15-99, England & Wales. [cited 2017 Avg 15]. Available at: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://info.cancerresearchuk.org/cancerstats/faqs/#How">http://info.cancerresearchuk.org/cancerstats/faqs/#How</ext-link>.
Arora RS, Alston RD, Eden TO, Estlin EJ, Moran A, Geraci M, et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979–2003. <em>Eur J Cancer</em> 2010; <bold>46</bold>: 1607-16. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ejca.2010.02.007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejca.2010.02.007</a></pub-id>
Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. <em>Neuro Oncol</em> 2012; <bold>14(Suppl 5)</bold>: v1–49. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/neuonc/nos218" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/neuonc/nos218</a></pub-id>
Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, et al. CBTRUS statistical report: primary brain and central nervous aystem tumors diagnosed in the United States in 2008-2012. <em>Neuro Oncol</em> 2015; <bold>17(Suppl 4)</bold>: iv1-62. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/neuonc/nov189" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/neuonc/nov189</a></pub-id>
<em>Cancer incidence in Slovenia1997-2006</em>. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2000-2009.
<em>Cancer in Slovenia 2007-11</em>. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2010-2014.
Smrdel U, Kovac V, Popovic M, Zwitter M. Glioblastoma patients in Slovenia from 1997 to 2008. <em>Radiol Oncol</em> 2014; <bold>48</bold>: 72-9. <pub-id pub-id-type="doi"><a href="https://doi.org/10.2478/raon-2014-0002" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2478/raon-2014-0002</a></pub-id>
Steinfeld AD, Donahue B, Walker I. Delay in the diagnosis of glioblastoma multiforme: is age a factor? <em>Cancer Invest</em> 1996; <bold>14</bold>: 317-9.
Crespo I, Vital AL, Gonzalez-Tablas M, Patino M del C, Otero A, Lopes MC, et al. Molecular and genomic alterations in glioblastoma multiforme. <em>Am J Pathol</em> 2015; <bold>185</bold>: 1820-33. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ajpath.2015.02.023" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ajpath.2015.02.023</a></pub-id>
De Groot JF, Aldape KD CH. High-grade astrocytomas. In: Schiff D, On B, editors. <em>Principles of neuro-oncology</em>. New York: McGraw Hill; 2005. p. 259-88.
Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ, et al. Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. <em>Int J Radiat Oncol Biol Phys</em> 2011; <bold>81</bold>: 623-30. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijrobp.2010.06.012" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijrobp.2010.06.012</a></pub-id>
Statistical Office, Republic of Slovenia. Births and deaths. [Internet]. [cited 2017 Nov 19]. Available at: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.stat.si/StatWeb/Field/Index/17/95">http://www.stat.si/StatWeb/Field/Index/17/95</ext-link>
OECDiLibrary. Health at a glance 2017. [Internet]. OECD Publishing; 2017 [cited 2017 Nov 19]. Available at: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-en">http://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-en</ext-link>
Fiorentino A, De Bonis P, Chiesa S, Balducci M, Fusco V. Elderly patients with glioblastoma: the treatment challenge. <em>Expert Rev Neurother</em> 2013; <bold>13</bold>: 1099-105. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1586/14737175.2013.840419" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1586/14737175.2013.840419</a></pub-id>
Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daudé H, Rigau V, Fabro M, et al. Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France. <em>Neurosurg Rev</em> 2014; <bold>3</bold>: 415-23. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s10143-014-0528-8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s10143-014-0528-8</a></pub-id>
Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al. Radiotherapy for glioblastoma in the elderly. <em>N Eng J Med</em> 2007; <bold>356</bold>: 1527-35. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1056/NEJMoa065901" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1056/NEJMoa065901</a></pub-id>